ID

29019

Description

Study part: Verteporfin Therapy (Unscheduled). A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.

Keywords

Versions (1)
  1. 2/20/18 2/20/18 -
Copyright Holder

Roche

Uploaded on

February 20, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Verteporfin Therapy (Unscheduled) rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g

English

Verteporfin Therapy (Unscheduled)

1 forms  
VERTEPORFIN THERAPY (UNSCHEDULED)
Description

VERTEPORFIN THERAPY (UNSCHEDULED)

Alias
UMLS CUI-1
C0087111
Subject Number:
Description

Subject Number

Data type

text

Alias
UMLS CUI [1]
C2348585
Subject Initials:
Description

Subject Initials

Data type

text

Alias
UMLS CUI [1,1]
C1997894
UMLS CUI [1,2]
C2986440
Visit Date:
Description

Visit Date

Data type

date

Alias
UMLS CUI [1]
C1320303
Indication code
Description

Indication

Data type

text

Alias
UMLS CUI [1]
C3146298
Date Administered
Description

Date Administered

Data type

date

Alias
UMLS CUI [1,1]
C1533734
UMLS CUI [1,2]
C0011008
Infusion Start Time
Description

Infusion Start Time

Data type

time

Alias
UMLS CUI [1,1]
C1301880
UMLS CUI [1,2]
C0574032
Total Dose Administered
Description

Total Dose

Data type

text

Measurement units
  • mg
Alias
UMLS CUI [1]
C2986497
mg
Eye treated
Description

Eye

Data type

text

Alias
UMLS CUI [1]
C0015392
Back to the top of the page

Similar models

Verteporfin Therapy (Unscheduled)

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
VERTEPORFIN THERAPY (UNSCHEDULED)
C0087111 (UMLS CUI-1)
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
date
C1320303 (UMLS CUI [1])
Item
Indication code
text
C3146298 (UMLS CUI [1])
Indication
Code List
Indication code
CL Item
Predominantly classic subfoveal CNV due to AMD  (1)
C0242383 (UMLS CUI-1)
(Comment:en)
CL Item
Subfoveal CNV due to pathologic myopia  (2)
C0027092 (UMLS CUI-1)
(Comment:en)
CL Item
Subfoveal CNV due to presumed ocular histoplasmosis (3)
C1562543 (UMLS CUI-1)
(Comment:en)
CL Item
Other (99)
C0205394 (UMLS CUI-1)
(Comment:en)
Date Administered
Item
Date Administered
date
C1533734 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Infusion Start Time
Item
Infusion Start Time
time
C1301880 (UMLS CUI [1,1])
C0574032 (UMLS CUI [1,2])
Total Dose
Item
Total Dose Administered
text
C2986497 (UMLS CUI [1])
Item
Eye treated
text
C0015392 (UMLS CUI [1])
Eye
Code List
Eye treated
CL Item
OD (OD)
C0229089 (UMLS CUI-1)
(Comment:en)
CL Item
OS (OS)
C0229090 (UMLS CUI-1)
(Comment:en)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial